156 related articles for article (PubMed ID: 29669207)
1. ROS-Inducing Micelles Sensitize Tumor-Associated Macrophages to TLR3 Stimulation for Potent Immunotherapy.
Liu L; He H; Liang R; Yi H; Meng X; Chen Z; Pan H; Ma Y; Cai L
Biomacromolecules; 2018 Jun; 19(6):2146-2155. PubMed ID: 29669207
[TBL] [Abstract][Full Text] [Related]
2. Tumor associated macrophage-targeted microRNA delivery with dual-responsive polypeptide nanovectors for anti-cancer therapy.
Liu L; Yi H; He H; Pan H; Cai L; Ma Y
Biomaterials; 2017 Jul; 134():166-179. PubMed ID: 28463694
[TBL] [Abstract][Full Text] [Related]
3. Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo.
Luo Z; Wang C; Yi H; Li P; Pan H; Liu L; Cai L; Ma Y
Biomaterials; 2015 Jan; 38():50-60. PubMed ID: 25457983
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor macrophages activated by ferumoxytol combined or surface-functionalized with the TLR3 agonist poly (I : C) promote melanoma regression.
Zhao J; Zhang Z; Xue Y; Wang G; Cheng Y; Pan Y; Zhao S; Hou Y
Theranostics; 2018; 8(22):6307-6321. PubMed ID: 30613299
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional Redox-Responsive Nanoplatform with Dual Activation of Macrophages and T Cells for Antitumor Immunotherapy.
Zhang W; Liu X; Cao S; Zhang Q; Chen X; Luo W; Tan J; Xu X; Tian J; Saw PE; Luo B
ACS Nano; 2023 Aug; 17(15):14424-14441. PubMed ID: 37498878
[TBL] [Abstract][Full Text] [Related]
6. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional biomimetic nanoparticles loading baicalin for polarizing tumor-associated macrophages.
Han S; Wang W; Wang S; Wang S; Ju R; Pan Z; Yang T; Zhang G; Wang H; Wang L
Nanoscale; 2019 Nov; 11(42):20206-20220. PubMed ID: 31621735
[TBL] [Abstract][Full Text] [Related]
8. Activation of NK cell cytotoxicity by aerosolized CpG-ODN/poly(I:C) against lung melanoma metastases is mediated by alveolar macrophages.
Sommariva M; Le Noci V; Storti C; Bianchi F; Tagliabue E; Balsari A; Sfondrini L
Cell Immunol; 2017 Mar; 313():52-58. PubMed ID: 28089340
[TBL] [Abstract][Full Text] [Related]
9. Spatially targeting and regulating tumor-associated macrophages using a raspberry-like micellar system sensitizes pancreatic cancer chemoimmunotherapy.
Li T; Chen D; Liu H; Tao Y; He X; Zang S; Li J; Zhang L; Li M; Liu J; He Q
Nanoscale; 2022 Sep; 14(36):13098-13112. PubMed ID: 35972382
[TBL] [Abstract][Full Text] [Related]
10. Lymph Node Delivery Strategy Enables the Activation of Cytotoxic T Lymphocytes and Natural Killer Cells to Augment Cancer Immunotherapy.
Jiang D; Gao T; Liang S; Mu W; Fu S; Liu Y; Yang R; Zhang Z; Liu Y; Zhang N
ACS Appl Mater Interfaces; 2021 May; 13(19):22213-22224. PubMed ID: 33955746
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance.
Chin AI; Miyahira AK; Covarrubias A; Teague J; Guo B; Dempsey PW; Cheng G
Cancer Res; 2010 Apr; 70(7):2595-603. PubMed ID: 20233880
[TBL] [Abstract][Full Text] [Related]
12. Effective cancer immunotherapy in mice by polyIC-imiquimod complexes and engineered magnetic nanoparticles.
Bocanegra Gondan AI; Ruiz-de-Angulo A; Zabaleta A; Gómez Blanco N; Cobaleda-Siles BM; García-Granda MJ; Padro D; Llop J; Arnaiz B; Gato M; Escors D; Mareque-Rivas JC
Biomaterials; 2018 Jul; 170():95-115. PubMed ID: 29656235
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming Tumor-Associated Macrophages by Nanoparticle-Based Reactive Oxygen Species Photogeneration.
Shi C; Liu T; Guo Z; Zhuang R; Zhang X; Chen X
Nano Lett; 2018 Nov; 18(11):7330-7342. PubMed ID: 30339753
[TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal administration of poly(I:C) with polyethylenimine leads to significant antitumor immunity against murine ovarian tumors.
Wu CY; Yang HY; Monie A; Ma B; Tsai HH; Wu TC; Hung CF
Cancer Immunol Immunother; 2011 Aug; 60(8):1085-96. PubMed ID: 21526359
[TBL] [Abstract][Full Text] [Related]
15. Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells.
Eisinger S; Sarhan D; Boura VF; Ibarlucea-Benitez I; Tyystjärvi S; Oliynyk G; Arsenian-Henriksson M; Lane D; Wikström SL; Kiessling R; Virgilio T; Gonzalez SF; Kaczynska D; Kanatani S; Daskalaki E; Wheelock CE; Sedimbi S; Chambers BJ; Ravetch JV; Karlsson MCI
Proc Natl Acad Sci U S A; 2020 Dec; 117(50):32005-32016. PubMed ID: 33229588
[TBL] [Abstract][Full Text] [Related]
16. Self-Associating Poly(ethylene oxide)-block-poly(α-carboxyl-ε-caprolactone) Drug Conjugates for the Delivery of STAT3 Inhibitor JSI-124: Potential Application in Cancer Immunotherapy.
Garg SM; Vakili MR; Molavi O; Lavasanifar A
Mol Pharm; 2017 Aug; 14(8):2570-2584. PubMed ID: 28221800
[TBL] [Abstract][Full Text] [Related]
17. Dual Inhibition of Endoplasmic Reticulum Stress and Oxidation Stress Manipulates the Polarization of Macrophages under Hypoxia to Sensitize Immunotherapy.
Jiang M; Li X; Zhang J; Lu Y; Shi Y; Zhu C; Liu Y; Qin B; Luo Z; Du Y; Luo L; Peng L; You J
ACS Nano; 2021 Sep; 15(9):14522-14534. PubMed ID: 34414762
[TBL] [Abstract][Full Text] [Related]
18. M2-polarized and tumor-associated macrophages alter NK cell phenotype and function in a contact-dependent manner.
Krneta T; Gillgrass A; Poznanski S; Chew M; Lee AJ; Kolb M; Ashkar AA
J Leukoc Biol; 2017 Jan; 101(1):285-295. PubMed ID: 27493241
[TBL] [Abstract][Full Text] [Related]
19. Dual pH-sensitive oxidative stress generating micellar nanoparticles as a novel anticancer therapeutic agent.
Park S; Kwon B; Yang W; Han E; Yoo W; Kwon BM; Lee D
J Control Release; 2014 Dec; 196():19-27. PubMed ID: 25278257
[TBL] [Abstract][Full Text] [Related]
20. Targeted Delivery of Dasatinib to Deplete Tumor-Associated Macrophages by Mannosylated Mixed Micelles for Tumor Immunotherapy.
Zhang X; Zang X; Qiao M; Zhao X; Hu H; Chen D
ACS Biomater Sci Eng; 2020 Oct; 6(10):5675-5684. PubMed ID: 33320562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]